ALS

Amylyx asks FDA to approve ALS drug, while also preparing late-stage study
BioPharma Dive
Tue, 11/2/21 - 10:58 am
Amylyx Pharmaceuticals
AMX-0035
FDA
ALS
ANA 2021 – Ionis rocked by tofersen flop
EP Vantage
Mon, 10/18/21 - 10:58 am
Biogen
Ionis Pharmaceuticals
clinical trials
ALS
tofersen
Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS
Yahoo Finance
Sun, 10/17/21 - 11:04 pm
Biogen
tofersen
clinical trials
ALS
Denali Moving Forward with Sanofi-Partnered ALS Candidate
BioSpace
Thu, 10/7/21 - 12:17 pm
Denali Therapeutics
Sanofi
ALS
DNL343
clinical trials
Biogen leads the amyotrophic lateral sclerosis hopefuls
EP Vantage
Thu, 09/16/21 - 10:41 am
ALS
Amylx
Biogen
Ionis Pharmaceuticals
AB Science
Cytokinetics
After talks with FDA, a biotech prepares to submit its closely watched ALS drug
BioPharma Dive
Wed, 09/15/21 - 10:48 am
Amylyx Pharmaceuticals
FDA
ALS
AMX-0035
AZ’s Alexion takeover hits a snag, as Ultomiris flunks ALS trial
Pharmaforum
Sun, 08/22/21 - 09:50 pm
AstraZeneca
Ultomiris
ALS
Treg cell therapy showing promise in ALS trials: Coya Therapeutics
Biopharma Reporter
Mon, 08/2/21 - 09:34 pm
Coya Therapeutics
ALS
Treg cell therapy
clinical trials
Amylyx, faced with longer FDA path for promising ALS drug, gets major cash infusion
BioPharma Dive
Tue, 07/20/21 - 12:31 pm
Amylyx Pharmaceuticals
ALS
venture capital
FDA
AMX0035
AB Science Announces Significant Survival Data for Masitinib in ALS
BioSpace
Tue, 07/20/21 - 11:02 am
AB Science
ALS
clinical trials
masitinib
Eli Lilly makes modest bet on 'all-in-human' discovery outfit for ALS drugs, deepening bid in precision neurology
Endpoints
Thu, 07/8/21 - 11:02 am
Eli Lilly
Verge Genomics
drug development
drug discovery
artificial intelligence
ALS
Alzheimer's disease
Promised EAP Date Approaching for Biogen's Highly Publicized ALS Drug
BioSpace
Wed, 06/30/21 - 12:13 am
Biogen
tofersen
ALS
VectorY raises $38M to develop Alzheimer's, ALS gene therapies
Fierce Biotech
Tue, 06/15/21 - 11:37 pm
VectorY Therapeutics
gene therapy
ALS
Alzheimer's disease
CRISPR Therapeutics takes a swing at ALS gene editing in discovery deal with AAV upstart Capsida
Endpoints
Tue, 06/15/21 - 10:37 am
CRISPR Therapeutics
ALS
gene editing
Capsida
NurOwn: A Study in the Complexity of ALS Trials
BioSpace
Tue, 05/4/21 - 10:44 pm
BrainStorm Cell Therapeutics
NurOwn
ALS
clinical trials
Following pressure, Biogen to start compassionate use program for ALS drug tofersen
Seeking Alpha
Tue, 04/27/21 - 10:58 am
Biogen
ALS
tofersen
compassionate use guidelines
Amylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
MedCity News
Thu, 04/15/21 - 11:56 pm
Amylyx
ALS
clinical trials
FDA
FDA faces backlash after seeking more data on an experimental ALS therapy
BioPharma Dive
Wed, 04/14/21 - 09:53 pm
ALS
AMX0035
Amylyx Pharmaceuticals
FDA
Ionis' Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More
BioSpace
Wed, 04/7/21 - 07:15 pm
Ionis Pharmaceuticals
Progenity
ALS
clinical trials
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
MedCity News
Thu, 03/4/21 - 09:53 am
BrainStorm Cell Therapeutics
ALS
stem cell therapy
clinical trials
FDA

Pages